Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

81.

Bacterial RNA polymerase can retain σ70 throughout transcription.

Proc. Natl. Acad. Sci. U.S.A.
Harden TT, Wells CD, Friedman LJ, Landick R, Hochschild A, Kondev J, Gelles J.
| Jan 19, 2016
82.

Multidrug evolutionary strategies to reverse antibiotic resistance.

Science.
Baym M, Stone LK, Kishony R.
| Jan 1, 2016
83.

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.

Science.
Tabebordbar M, Zhu K, Cheng JK, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, Cong L, Zhang F, Vandenberghe LH, Church GM, Wagers AJ.
| Jan 22, 2016
84.

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Science.
Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA.
| Jan 22, 2016
85.

Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.

Proc. Natl. Acad. Sci. U.S.A.
Agarwal S, Loder S, Brownley C, Cholok D, Mangiavini L, Li J, Breuler C, Sung HH, Li S, Ranganathan K, Peterson J, Tompkins R, Herndon D, Xiao W, Jumlongras D, Olsen BR, Davis TA, Mishina Y, Schipani E, Levi B.
| Jan 19, 2016
87.

Reply to Davis: Nitric oxide regulates lymphatic contractions.

Proc. Natl. Acad. Sci. U.S.A.
Kunert C, Baish JW, Liao S, Padera TP, Munn LL.
| Jan 12, 2016
89.

Choosing Benefits while Balancing Risks.

N. Engl. J. Med.
Greene MF, Ecker JL.
| Dec 31, 2015
90.

A cell wall damage response mediated by a sensor kinase/response regulator pair enables beta-lactam tolerance.

Proc. Natl. Acad. Sci. U.S.A.
Dörr T, Alvarez L, Delgado F, Davis BM, Cava F, Waldor MK.
| Jan 12, 2016
91.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Lancet.
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ.
| Dec 17, 2015
92.

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME.
| Dec 15, 2015
93.

Insulator dysfunction and oncogene activation in IDH mutant gliomas.

Nature.
Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, Suvà ML, Bernstein BE.
| Jan 7, 2016
94.

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Proc. Natl. Acad. Sci. U.S.A.
Weinstein S, Toker IA, Emmanuel R, Ramishetti S, Hazan-Halevy I, Rosenblum D, Goldsmith M, Abraham A, Benjamini O, Bairey O, Raanani P, Nagler A, Lieberman J, Peer D.
| Jan 5, 2016
95.

APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.

Proc. Natl. Acad. Sci. U.S.A.
Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR.
| Jan 26, 2016
96.

Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain.

Proc. Natl. Acad. Sci. U.S.A.
Bolduc DM, Montagna DR, Gu Y, Selkoe DJ, Wolfe MS.
| Feb 2, 2016
97.

High risk of near-crash driving events following night-shift work.

Proc. Natl. Acad. Sci. U.S.A.
Lee ML, Howard ME, Horrey WJ, Liang Y, Anderson C, Shreeve MS, O'Brien CS, Czeisler CA.
| Jan 5, 2016
98.

Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity.

Proc. Natl. Acad. Sci. U.S.A.
Singhal PK, Sassi S, Lan L, Au P, Halvorsen SC, Fukumura D, Jain RK, Seed B.
| Jan 5, 2016
99.

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

N. Engl. J. Med.
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV, Williams PG, Beghetti M, Corris P, Pepke-Zaba J, Souza R, DeMets DL, Gomberg-Maitland M, Greenberg BH, Schulman S, Douketis J, Amuchastegui M.
| Dec 24, 2015
100.

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.

N. Engl. J. Med.
Shaw AT, Friboulet L, Leshchiner I, Gainor JF, Bergqvist S, Brooun A, Burke BJ, Deng YL, Liu W, Dardaei L, Frias RL, Schultz KR, Logan J, James LP, Smeal T, Timofeevski S, Katayama R, Iafrate AJ, Le L, McTigue M, Getz G, Johnson TW, Engelman JA.
| Jan 7, 2016